Education
About Us
Working with TipRanks
Follow Us
BB Biotech AG (CH:BION)
:BION
BION Stock Chart & Stats
CHF49.35
CHF0.10(0.27%)
At close: 4:00 PM EST
CHF49.35
CHF0.10(0.27%)
Day’s Range― - ―
52-Week RangeCHF24.35 - CHF49.65
Previous CloseN/A
Volume20.47K
Average Volume (3M)98.23K
Market Cap
CHF2.58B
Enterprise ValueCHF2.73B
Total Cash (Recent Filing)CHF2.16M
Total Debt (Recent Filing)CHF0.00
Price to Earnings (P/E)16.1
Beta0.96
Next Earnings
Apr 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.95%
Share Statistics
EPS (TTM)N/A
Shares Outstanding55,400,000
10 Day Avg. Volume119,513
30 Day Avg. Volume98,228
Financial Highlights & Ratios
PEG Ratio-0.19
Price to Book (P/B)0.85
Price to Sales (P/S)17.44
P/FCF Ratio6.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BB Biotech News
BION FAQ
What was BB Biotech AG’s price range in the past 12 months?
BB Biotech AG lowest stock price was CHF24.35 and its highest was CHF49.65 in the past 12 months.
What is BB Biotech AG’s market cap?
BB Biotech AG’s market cap is CHF2.58B.
When is BB Biotech AG’s upcoming earnings report date?
BB Biotech AG’s upcoming earnings report date is Apr 24, 2026 which is in 90 days.
How were BB Biotech AG’s earnings last quarter?
Currently, no data Available
Is BB Biotech AG overvalued?
According to Wall Street analysts BB Biotech AG’s price is currently Overvalued.
Does BB Biotech AG pay dividends?
BB Biotech AG pays a Annually dividend of CHF1.8 which represents an annual dividend yield of 3.95%. See more information on BB Biotech AG dividends here
What is BB Biotech AG’s EPS estimate?
BB Biotech AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BB Biotech AG have?
BB Biotech AG has 55,400,000 shares outstanding.
What happened to BB Biotech AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BB Biotech AG?
Currently, no hedge funds are holding shares in CH:BION
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BB Biotech AG
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Technical Analysis
Molecular Partners AG
―
Basilea Pharmaceutica
―
Idorsia Ltd
―
Kuros Biosciences
―
Newron Pharmaceuticals SpA
―
Ownership Overview
― Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
99.02% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---